David Alan Campbell

Insider Reports History

Location
La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Alan Campbell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. President and CEO, Director Common Stock 381,582 $6,051,890 $15.86 02 Jan 2026 Direct
Janux Therapeutics, Inc. President and CEO, Director Stock option (right to buy) 338,100 02 Jan 2026 Direct

Insider Reports Filed by David Alan Campbell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2026 3 -$110,829 4 President and CEO, Director 02 Jan 2026, 21:00
JANX Janux Therapeutics, Inc. 07 Jan 2025 1 -$300,004 4 President and CEO, Director 08 Jan 2025, 20:00
JANX Janux Therapeutics, Inc. 02 Jan 2025 2 $0 4 President and CEO, Director 03 Jan 2025, 20:10
JANX Janux Therapeutics, Inc. 24 Dec 2024 1 -$1,404,805 4 President and CEO, Director 27 Dec 2024, 20:00
JANX Janux Therapeutics, Inc. 03 Dec 2024 1 -$1,005,000 4 President and CEO, Director 03 Dec 2024, 20:00
JANX Janux Therapeutics, Inc. 25 Nov 2024 2 -$1,289,879 4 President and CEO, Director 27 Nov 2024, 20:00
JANX Janux Therapeutics, Inc. 28 Oct 2024 2 -$1,338,559 4 President and CEO, Director 30 Oct 2024, 19:30
JANX Janux Therapeutics, Inc. 27 Sep 2024 3 -$1,157,641 4 President and CEO, Director 27 Sep 2024, 19:30
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 President and CEO, Director 03 Jan 2024, 16:49
JANX Janux Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Executive Officer, Director 05 Jan 2023, 15:30
JANX Janux Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Executive Officer, Director 05 Jan 2022, 16:21
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Chief Executive Officer, Director 10 Jun 2021, 19:02